• 1
    MacDougall DF, Cook T., Steward AP, et al. Canine chronic renal disease: prevalence and types of glomerulonephritis in the dog. Kidney International 1986;29:11441151.
  • 2
    Burkholder PM. Immunopathology of renal disease. Clin North Amer 1986;6:5583.
  • 3
    Page RL, Stiff ME, McEntee MC, et al. Transient glomerulonephropathy associated with primary erythrocytosis in a dog. J Am Vet Med Assoc 1990;196:620622.
  • 4
    Ponticelli C., Rivolta E. Cyclosporine in nephrotic syndrome. Transplant Proc 1988;20(suppl 4):253258.
  • 5
    Glassock RJ, Adler SG, Ward HJ, et al. Primary glomerular diseases. In: BrennerBM, RectorFC, eds. The kidney. Philadelphia , PA : WB Saunders, 1991;11821279.
  • 6
    Vaden SL, Grauer GF. Medical management of canine glomerulonephritis, In: KirkRW (ed) Current Veterinary Therapy XI. Philadelphia , PA , WB Saunders, 1992;861864.
  • 7
    Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136142.
  • 8
    Carothers MA, Kwochka KW, Rojko JL. Cyclosporine-responsive granulomatous sebaceous adenitis in a dog. J Am Vet Med Assoc 198:16451648, 1991.
  • 9
    Gregory CR, Gourley IM, Kochin EJ, et al. Renal transplantation for treatment of end-stage renal failure in cats. J Am Vet Med Assoc 201:285291, 1992.
  • 10
    Gregory CR, Gourley IM, Taylor NJ, et al. Preliminary results of clinical allograft transplantation in the dog and cat. J Vet Intern Med 1987;1:5360.
  • 11
    Morgan RV, Abrams KL. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs. J Am Vet Med Assoc 199:10431046, 1991.
  • 12
    Rosenkrantz WS, Griffin CE, Barr RJ. Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotrophic lymphoma. J Am Anim Hosp Assoc 1989;25:377384.
  • 13
    Schrijver G., Wetzels JFM, Robben JCM, et al. Antiproteinuric effect of cyclosporine A in passive antiglomerular basement membrane nephritis in the mouse. Transplant Proc 1988;20(suppl 4):304308.
  • 14
    Thaiss F., Mihatsch MJ, Batsford S., et al. Effect of cyclosporine on in situ immune complex glomerulonephritis. Clin Nephrol 1986;25(suppl 1):S181S185.
  • 15
    Tipping PG, Holdsworth SR. Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron 1985;40:201205.
  • 16
    Erbay B., Karatan O., Duman N., et al. The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Transplant Proc 1988, 20(suppl 4):289292.
  • 17
    Zietse R., Wenting GJ, Kramer P., et al. Fractional excretion of protein: A marker of the efficacy of cyclosporine a treatment in nephrotic syndrome. Transplant Proc 1988;20(suppl 4):280284.
  • 18
    Clasen W., Kindler J., Mihatsch MJ, et al. Long-term treatment of minimal change nephrotic syndrome with cyclosporin: a control biopsy study. Nephol Dial Transplant 1988;3:733737.
  • 19
    Garin EH, Orak JK, Hiott KL, et al. Cyclosporine therapy for steroid resistant nephrotic syndrome. Am J Dis Child 1988;142: 985988.
  • 20
    Maher ER, Sweny P., Chappel M., et al. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988;3:728732.
  • 21
    Meyrier A., Condamin MC, Simon P. Treatment with cyclosporine of adult idiopathic nephrotic syndrome resistant to corticosteroids and other immunosuppressants. Transplant Proc 1988, 20(suppl 4):259261.
  • 22
    Tejani A., Gonzalez R., Rajpoot D., et al. A randomized trial of cyclosporine with low-dose prednisone compared with high-dose prednisone in nephrotic syndrome. Transplant Proc 1988;20(suppl 4):262264.
  • 23
    Barnett EV, Knutson DW, Abrass CK, et al. Circulating immune complexes: Their immunochemistry, detection, and importance. Ann Intern Med 1979;91:430440.
  • 24
    DeBoer DJ, Ihrke PJ, Stannard AA. Circulating immune complex concentrations in selected cases of skin diseases in dogs. Am J Vet Res 1988;49:143146.
  • 25
    Soiling J. Circulating immune complexes in glomerulonephritis: A longitudinal study. Clin Nephrol 1983;20:177189.
  • 26
    Snedecor GW, Cochran WG. Statistical Methods, 8th ed. Ames , IA : Iowa State University Press; 1989;2634; 142–144; 177.
  • 27
    Lee ET. Statistical Methods for Survival Data Analysis. Belmont , CA : Lifetime Learning Publications, 1980;1929; 250–259.
  • 28
    White JV, Davis WR, Nachreiner R., et al. Cyclosporine pharmacokinetics in normal and pancrectomized dogs. Transplantation 1986;42:390395.
  • 29
    Takaori K., Nio Y., Inoue K., et al. A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. Biotherapy 1992;4:129137.
  • 30
    Bohle A., Mackensen-Haen S., von Gise, et al. The consequences of tubulo-interstitial changes for renal function in glomerulonephropathies. A morphometric and cytological analysis. Pathol Res Pract 1990;186: 135144.
  • 31
    Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 1988;34:382388.
  • 32
    Orofino L., Greifer I., Bennet BP, et al. Hypertension in primary chronic glomerulonephritis: Analysis of 288 biopsied patients. Nephron 1987;45:2226.
  • 33
    Park MH, Agati VD, Appel GB, et al. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function and prognosis. Nephron 1986;44:309319.
  • 34
    Payton CD, McLay A., Boulton Jones JM. Progressive IgA nephropathy: The role of hypertension. Nephrol Dial Transplant 1988;2:138142.
  • 35
    Heeg JE, de Jong PE, van der Hem GK, et al. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987;32:7883.
  • 36
    Grauer GF, Grisbie DD, Snyder PS, et al. Treatment of membranoproliferative glomerulonephritis and nephrotic syndrome in a dog with thromboxane synthetase inhibitor. J Vet Intern Med 1992;6:7781.
  • 37
    Grauer GF, Frisbie DD, Longhofer SL, et al. Effects of thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs. Am J Vet Res 1992;53:808813.
  • 38
    Polzin DJ, Osborne CA. The importance of egg protein in reduced protein diets designed for dogs with renal failure. J Vet Intern Med 1988;2:1521.
  • 39
    Ptachinski RJ, Venkataramanan R., Burckart GJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinetics 1986;11: 107132.
  • 40
    Painvin GA, Heimbecker RO, Keown PA, et al. The side effects of cyclosporin A: Clinical and histologic findings following 31 canine heterotopic cardiac allotransplants. Curr Surg 1983;40: 120122.
  • 41
    Aeder MI, Sutherland LD, Bowers RK, et al. Cyclosporin toxicity in a canine model: clinical, histologic, and immunologic studies. Transplant Proc 1984;16:16321633.
  • 42
    Grekas D., Alivanis P., Kalekou H., et al. Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents. Renal Failure 1992;14:493498.
  • 43
    Wahlstrom HE, Akimoto R., Endres D., et al. Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment. Transplantation 1992;53:11901195.
  • 44
    Feldman E., Alejandro R., Mintz D. Biochemical alterations in dogs receiving long-term cyclosporine therapy. Proc of the 5th Annual Vet Med Forum 1987;916.
  • 45
    Lorber MI, van Buren CT, Flechner SM, et al. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation 1987;43:3540.
  • 46
    Penn I. Cancers following cyclosporine therapy. Transplantation 1987;43:3235.
  • 47
    Grace AA, Barradas MA, Mikhailidis DP, et al. Cyclosporine A enhances platelet aggregation. Kidney Int 1987;32:889895.
  • 48
    Cockburn I., Götz I., Gülich A., et al. An interim analysis of the on-going long-term safety study of cyclosporine in renal transplantation. Transplant Proc 1988;20(suppl 3):519529.
  • 49
    White JV, Olivier NB, Reimann K., et al. Use of protein-to-creatinine ratio in a single urine specimen for quantitative estimation of canine proteinuria. J Am Vet Med Assoc 1984;185:882885.
  • 50
    Grauer GF, Thomas CB, Eicker SW. Estimation of quantitative proteinuria in the dog, using the urine protein-to-creatinine ratio from a random, voided sample. Am J Vet Res 1985;46:21162119.
  • 51
    Adams LG, Polzin DJ, Osborne CA. Correlation of urine protein/creatinine ratio and twenty-four hour urinary protein excretion in normal cats and cats with surgically induced chronic renal failure. J Vet Intern Med 1989;6:3640.
  • 52
    Center SA, Wilkinson E., Smith CA, et al. 24-hour urine protein/creatinine ratio in dogs with protein-losing nephropathies. J Am Vet Med Assoc 1985;187:820824.